Breaking News Instant updates and real-time market news.

KALA

Kala Pharmaceuticals

$9.25

-0.38 (-3.95%)

16:18
10/02/18
10/02
16:18
10/02/18
16:18

Kala Pharmaceuticals files to sell 7.5M shares of common stock

J.P. Morgan, BofA Merrill Lynch and Jefferies will act as joint bookrunning managers for the offering. Cantor Fitzgerald & Co. is serving as lead manager for the offering, and Wedbush PacGrow and Oppenheimer & Co. Inc. are acting as co-managers for the offering.

KALA Kala Pharmaceuticals
$9.25

-0.38 (-3.95%)

06/19/18
WELS
06/19/18
NO CHANGE
Target $19
WELS
Outperform
Kala Pharma's KPI-121 update suggests faster market entry, Wells Fargo says
Wells Fargo analyst David Maris kept his Outperform rating and $19 price target on Kala Pharmaceuticals, saying its announced plans to submit a new drug application for KPI-121 to the FDA in the second half of the year may expedite its market entry. The analyst adds that the most likely scenario is for the FDA to accept the company's NDA for review but ultimately consider the Stride 3 data and issue a Complete Response Letter for an additional study, which will likely lead to a class 2 resubmission and a shortened 6-month review period. Maris contends that it is also possible that the FDA "accepts Kala's NDA, finds the existing data to be sufficient, and approves KPI-121 0.25% in its first review cycle, leading to a late-2019 or early 2020 commercialization.
07/23/18
HCWC
07/23/18
INITIATION
Target $35
HCWC
Buy
Kala Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Kala Pharmaceuticals with a Buy rating and $35 price target. The current valuation provides an "intriguing entry point" for investors ahead of the "risk-mitigated catalyst," the potential approval of Inveltys, Selvaraju tells investors in a research note. The analyst has "high confidence" that the drug should be approved in a "timely manner."
08/23/18
WELS
08/23/18
NO CHANGE
WELS
Outperform
FDA approval of Kala's Inveltys 'very positive news,' says Wells Fargo
Wells Fargo analyst David Maris says FDA approval of Kala Pharmaceuticals' Inveltys for post-operative pain inflammation and pain following ocular surgery is "very positive news." The analyst notes that Inveltys is the first and only twice- daily ocular steroid for this indication, as other products that are typically dosed at four times per day. Maris continue to believe Inveltys will be "very successful." He anticipates sales of approximately $25M in 2019, and $345M by 2025. The analyst keeps an Outperform rating on Kala amid the "sell-on-the-news reaction today."
08/24/18
HCWC
08/24/18
NO CHANGE
Target $37
HCWC
Buy
Kala Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Kala Pharmaceuticals to $37 after the FDA approved Inveltys for the treatment of post-operative inflammation and pain following all ocular surgeries. The approval is not only a risk-mitigating milestone for the company, but also crucial validation of its MPP technology, Selvaraju tells investors in a research note. The analyst reiterates a Buy rating on Kala Pharmaceuticals.

TODAY'S FREE FLY STORIES

15:20
10/19/18
10/19
15:20
10/19/18
15:20
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CLF

Cleveland-Cliffs

$10.92

-0.55 (-4.80%)

15:18
10/19/18
10/19
15:18
10/19/18
15:18
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CLF

Cleveland-Cliffs

$10.86

-0.61 (-5.32%)

15:17
10/19/18
10/19
15:17
10/19/18
15:17
Hot Stocks
Breaking Hot Stocks news story on Cleveland-Cliffs »

Cleveland-Cliffs CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/19/18
10/19
15:17
10/19/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRX

AcelRx

$3.77

-0.38 (-9.16%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Hot Stocks
AcelRx responds to FDA advisory committee opinions on Dsuvia »

In response to opinions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLF

Cleveland-Cliffs

$10.89

-0.58 (-5.06%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Hot Stocks
Cleveland-Cliffs CEO, after berating analysts, says would handle call same way »

Cleveland-Cliffs CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/19/18
10/19
15:16
10/19/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$127.73

-6.91 (-5.13%)

, STMP

Stamps.com

$194.61

-3.18 (-1.61%)

15:08
10/19/18
10/19
15:08
10/19/18
15:08
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

SHOP

Shopify

$127.73

-6.91 (-5.13%)

STMP

Stamps.com

$194.61

-3.18 (-1.61%)

BLK

BlackRock

$402.46

2.59 (0.65%)

BX

Blackstone

$34.82

-0.45 (-1.28%)

JPM

JPMorgan

$108.18

0.05 (0.05%)

F

Ford

$8.45

-0.055 (-0.65%)

GS

Goldman Sachs

$227.49

2.55 (1.13%)

GOOGL

Alphabet Class A

$1,104.29

7.06 (0.64%)

GOOG

Alphabet

$1,095.63

7.73 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Dec

  • 26

    Feb

  • 03

    Mar

ET

Energy Transfer LP

$17.01

0.19 (1.13%)

15:04
10/19/18
10/19
15:04
10/19/18
15:04
Hot Stocks
Energy Transfer LP: Binding Expansion Open Season for Bakken Pipeline System »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$37.87

-0.12 (-0.32%)

15:00
10/19/18
10/19
15:00
10/19/18
15:00
Options
Active trading in Halliburton ahead of earnings »

Active trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FXI

iShares China Large-Cap ETF

$39.39

0.7 (1.81%)

14:50
10/19/18
10/19
14:50
10/19/18
14:50
Options
32K iShares Large Cap China Fund Dec 42 - 44 call spreads trade for 40c »

32K iShares Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEVO

Gevo

$3.61

-0.08 (-2.17%)

, GPRE

Green Plains

$17.97

-0.38 (-2.07%)

14:48
10/19/18
10/19
14:48
10/19/18
14:48
Periodicals
Marathon weighs sale of high-ethanol gas in Minnesota, Bloomberg says »

Marathon Petroleum (MPC)…

GEVO

Gevo

$3.61

-0.08 (-2.17%)

GPRE

Green Plains

$17.97

-0.38 (-2.07%)

PEIX

Pacific Ethanol

$2.03

-0.12 (-5.58%)

MPC

Marathon Petroleum

$74.24

-4.6 (-5.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

CMCSA

Comcast

$35.94

-0.01 (-0.03%)

, CMCSK

Comcast

$0.00

(0.00%)

14:46
10/19/18
10/19
14:46
10/19/18
14:46
OnTheFly
Box Office Battle: 'Halloween' opening to add to massive October »

Comcast (CMCSA, CMCSK)…

CMCSA

Comcast

$35.94

-0.01 (-0.03%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.76

-0.28 (-0.50%)

T

AT&T

$32.84

0.34 (1.05%)

FOX

21st Century Fox

$45.33

-0.13 (-0.29%)

FOXA

21st Century Fox

$45.62

-0.19 (-0.41%)

DIS

Disney

$118.42

2.16 (1.86%)

LGF.A

Lionsgate

$22.17

-0.03 (-0.14%)

LGF.B

Lionsgate

$20.72

-0.06 (-0.29%)

VIA

Viacom

$36.75

-0.48 (-1.29%)

VIAB

Viacom

$33.30

-0.43 (-1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

FOSL

Fossil

$19.00

-0.13 (-0.68%)

14:40
10/19/18
10/19
14:40
10/19/18
14:40
Options
Far upside call buying in Fossil »

Far upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.67

-1.28 (-0.83%)

, GOOG

Alphabet

$1,090.00

2.1 (0.19%)

14:33
10/19/18
10/19
14:33
10/19/18
14:33
Hot Stocks
#SocialStocks: Snap may be small enough to be acquired, YouTube suffers blackout »

Welcome to…

FB

Facebook

$153.67

-1.28 (-0.83%)

GOOG

Alphabet

$1,090.00

2.1 (0.19%)

GOOGL

Alphabet Class A

$1,098.63

1.4 (0.13%)

TWTR

Twitter

$28.71

-0.58 (-1.98%)

SNAP

Snap

$6.75

-0.06 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 03

    Mar

ABBV

AbbVie

$88.84

-1.1 (-1.22%)

14:22
10/19/18
10/19
14:22
10/19/18
14:22
Recommendations
AbbVie analyst commentary  »

AbbVie's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 02

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/19/18
10/19
14:17
10/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/19/18
10/19
14:16
10/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPC

Marathon Petroleum

$74.58

-4.26 (-5.40%)

, PEIX

Pacific Ethanol

$1.98

-0.17 (-7.91%)

14:15
10/19/18
10/19
14:15
10/19/18
14:15
Periodicals
Marathon weighs sale of high-ethanol gas in Minnesota, Bloomberg says »

Companies levered to…

MPC

Marathon Petroleum

$74.58

-4.26 (-5.40%)

PEIX

Pacific Ethanol

$1.98

-0.17 (-7.91%)

GPRE

Green Plains

$17.91

-0.44 (-2.40%)

GEVO

Gevo

$3.61

-0.08 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

DHI

D.R. Horton

$35.98

-1.41 (-3.77%)

14:15
10/19/18
10/19
14:15
10/19/18
14:15
Options
D R Horton put volume heavy and directionally bearish »

Bearish flow noted in D R…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ABBV

AbbVie

$89.28

-0.66 (-0.73%)

14:11
10/19/18
10/19
14:11
10/19/18
14:11
Hot Stocks
AbbVie CFO to retire in mid-2019 »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 02

    Nov

CP

Canadian Pacific

$200.85

1.58 (0.79%)

14:06
10/19/18
10/19
14:06
10/19/18
14:06
Hot Stocks
Canadian Pacific reports Toronto Stock Exchange acceptance of buyback plan »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$47.68

-0.53 (-1.10%)

13:55
10/19/18
10/19
13:55
10/19/18
13:55
Options
Esperion put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

13:55
10/19/18
10/19
13:55
10/19/18
13:55
General news
More from Kaplan: 2 or 3 additional rate hikes »

More from Kaplan: 2 or 3…

13:55
10/19/18
10/19
13:55
10/19/18
13:55
General news
Action Economics Survey results »

Action Economics Survey…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.